Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis Healthcare
Metropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic acquisitions will also play a key role. The company aims to expand services beyond pathology. This strategy will drive future growth and strengthen its market position.
IRB Infra Trust offers to sell two BOT highway assets worth Rs 4,663 crore to IRB InvIT Fund
IRB Infrastructure Trust has offered two of its revenue-generating highway assets, valued at approximately Rs 4,663 crore, to IRB InvIT Fund. The non-binding offer includes the Solapur Yedeshi NH211 and Chittorgarh Gulabpura NH79 BOT Assets, totaling 1,144 Lane km. This move aims to fund future opportunities and enhance IRB InvIT Fund's asset portfolio.
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex jumps over 300 pts, Nifty above 23,500; Adani... - The Economic Times
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex jumps over 300 pts, Nifty above 23,500; Adani...The Economic Times
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
Fuel prices likely to increase in a phased manner, says Invesco's Taher Badshah
Taher Badshah, CIO at Invesco Mutual Fund, said fears around AI disrupting Indian IT companies may be overstated, noting that enterprise AI adoption remains costly and could eventually create service opportunities for Indian IT firms. Badshah added that valuations in the technology sector have corrected sharply, making select IT stocks attractive from a value-investing perspective.
Manipal Health acquires land, hospital in Mumbai’s Andheri for Rs 495 crore
Manipal Health Enterprises has made headlines by purchasing a hospital site in Andheri, Mumbai for Rs 495 crore. This acquisition is a slice of a broader Rs 908 crore deal, signaling a robust appetite for healthcare real estate among investors in major Indian cities.
Manipal Health buys Mumbai hospital asset for ₹495 crore in Andheri
Manipal Health Enterprises buys Andheri hospital asset in Mumbai for ₹495 crore from Khubchandani entities, deal registered May 6 2026, highlighting demand for healthcare real estate
Q4 Results Today: Blue Dart, Utkarsh Small Finance Bank, D-Link Among 30+ Firms To Declare Earnings
Sambhv Steel Tubes, Birla Corporation and Medi Assist Healthcare Services are among the key names that will declare their quarterly earnings on May 9.
From care to commerce: How phydigital healthcare is turning patient programmes into big business
India's healthcare is changing. Value is moving from hospitals to patients' daily lives. A new 'phydigital' model combines physical and digital care. This helps manage chronic diseases better. Patient Service Programmes are becoming a key business. This approach ensures continuous support for patients. It improves treatment adherence and outcomes. This trend is expanding beyond major cities.
GCC NRIs raise India equity bets; Motilal Oswal AMC gets NPS fund nod
GCC-based NRIs are increasing exposure to Indian equities while real estate sees outflows, as Motilal Oswal Asset Management Company enters the NPS pension fund space
Baroda BNP Paribas MF sees easing crude boosting rate-sensitive stocks, chemicals
Baroda BNP Paribas Mutual Fund Senior Fund Manager Jitendra Sriram said softer crude prices could improve sentiment for India and support interest rate-sensitive sectors. He believes refining, oil marketing and select specialty chemical companies may benefit if West Asia tensions ease. Sriram also cautioned that higher raw material and logistics costs may pressure corporate earnings over the next few quarters despite resilient recent results. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
52 of 112 FY26 IPOs below issue price; analysts advise selective buying
Stocks such as Anlon Healthcare, Jaro Institute, VMS TMT, Shree Ram Twistex and Glottis are down in the range of 50 to 80 per cent, as per data shared by PRIME Database.